SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-039496
Filing Date
2019-11-04
Accepted
2019-11-04 07:01:24
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20190930.htm 10-Q 1231492
2 EX-10.1 nerv-ex101_58.htm EX-10.1 276586
3 EX-3.2 nerv-ex32_112.htm EX-3.2 103833
4 EX-31.1 nerv-ex311_8.htm EX-31.1 17191
5 EX-31.2 nerv-ex312_6.htm EX-31.2 16748
6 EX-32.1 nerv-ex321_7.htm EX-32.1 9538
  Complete submission text file 0001564590-19-039496.txt   6024484

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nerv-20190930.xml EX-101.INS 1284030
8 XBRL TAXONOMY EXTENSION SCHEMA nerv-20190930.xsd EX-101.SCH 43818
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20190930_cal.xml EX-101.CAL 38457
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20190930_def.xml EX-101.DEF 173262
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20190930_lab.xml EX-101.LAB 378938
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20190930_pre.xml EX-101.PRE 294814
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 191188225
SIC: 2834 Pharmaceutical Preparations